Argenx Soars on Latest Trial Success for Autoimmune Drug Vyvgart

Argenx SE’s shares jumped after the European biotech reported the latest large, successful trial for its blockbuster drug Vyvgart.

By Naomi Kresge · Bloomberg Markets

Argenx SE’s shares jumped after the European biotech reported the latest large, successful trial for its blockbuster drug Vyvgart.